Sylvie Ryckebusch
Fortune : 81 986 $ au 31/05/2026
Fortune : 81 986 $ au 31/05/2026
Sylvie Ryckebusch currently holds the positions of Non-Executive Director at Domain Therapeutics SA and Chief Business Officer at BioInvent International AB since 2022.
The education history includes a doctorate from the California Institute of Technology and an undergraduate degree from the University of Maryland.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 31/12/2024 | 22 870 ( 0,03 % ) | 81 986 $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| BIOINVENT INTERNATIONAL AB | Corporate Officer/Principal | 09/06/2022 |
Domain Therapeutics SA
Domain Therapeutics SA BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that manufacture immuno-oncology and inflammation products | Directeur/Membre du Conseil | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 4 |
|---|---|
BioInvent International AB
BioInvent International AB BiotechnologyHealth Technology Develops and manufactures immunomodulatory antibodies for cancer treatment | Health Technology |
California Institute of Technology
California Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Maryland
University of Maryland Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Domain Therapeutics SA
Domain Therapeutics SA BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that manufacture immuno-oncology and inflammation products | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national